T. Kageura et al. / Bioorg. Med. Chem. 9 (2001) 1887–1893
1893
10 mM Tris, Complete Mini (1 tab/10 mL), 0.1% Triton
X-100, 2mM EGTA] and sonicated. After determina-
tion of protein concentration of each suspension by the
BCA method (BCATM Protein Assay Kit, Pierce), the
suspension was boiled in Laemmli buffer.18 For SDS-
PAGE, aliquots of 50 mg of protein from each sample
were subjected to electrophoresis in 10% poly-
acrylamide gels. Following electrophoresis, the proteins
were electrophoretically transferred onto nitrocellulose
membrane. The membrane were incubated with 5%
nonfat dried milk in Tris-buffered saline (TBS, 100 mM
NaCl, 10 mM Tris, 0.1% Tween 20, pH 7.4) and probed
with mouse monoclonal IgG (dilution of 1:1000) against
iNOS. The blots were washed in TBS and probed with
secondary antibody, anti-mouse IgG antibody con-
jugated to horseradish peroxidase (dilution of 1:5000).
Detection was performed using an ECL kit and X-ray
film (Hyper Film, Amersham).
counter (LS 6500, Beckman). Test compound was dis-
solved in DMSO and diluted with Tris–HCl buffer (pH
7.4) (final concentration of DMSO: 2%).
Statistical analysis
Values were expressed as meansÆSD or SEM One-way
analysis of variance following Dunnett’s test for multi-
ple comparison analysis were used for statistical analy-
sis. Probability (p) values less than 0.05 were considered
significant.
References and Notes
1. Kubo, M.; Ko, S.; Hiraba, K.; Harima, S.; Matsuda, H.;
Kim, I. J. Trad. Med. 1997, 14, 237.
2. Matsuda, H.; Morikawa, T.; Toguchida, I.; Park, J-Y.;
Harima, S.; Yoshikawa, M. Bioorg. Med. Chem. 2001, 9, 41.
3. Xia, Q.; Nathan, C. J. Leukoc. Biol. 1994, 56, 576.
4. Titheradge, M. A. Biochim. Biophys. Acta 1999, 1411, 437.
5. (a) Nussler, A. K.; Billiar, T. R. J. Leukoc. Biol. 1993, 54,
171. (b) Natarajan, K.; Singh, S.; Burke, T. R., Jr.; Grunber-
ger, D.; Aggarwal, B. B. Proc. Natl. Acad. Sci. U.S.A. 1996,
93, 9090.
6. (a) Matsuda, H.; Ninomiya, K.; Morikawa, T.; Yoshikawa,
M. Bioorg. Med. Chem. Lett. 1998, 8, 339. (b) Yoshikawa, M.;
Murakami, T.; Shimada, H.; Yoshizumi, S.; Saka, M.;
Yamahara, J.; Matsuda, H. Chem. Pharm. Bull. 1998, 46,
1008. (c) Matsuda, H.; Murakami, T.; Kageura, T.; Ninomiya,
K.; Toguchida, I.; Nishida, N.; Yoshikawa, M. Bioorg. Med.
Chem. Lett. 1998, 8, 2191. (d) Matsuda, H.; Kageura, T.;
Toguchida, I.; Murakami, T.; Kishi, A.; Yoshikawa, M.
Bioorg. Med. Chem. Lett. 1999, 9, 3081. (e) Yoshikawa, M.;
Morikawa, T.; Toguchida, I.; Harima, S.; Matsuda, H. Chem.
Pharm. Bull. 2000, 48, 651. (f) Matsuda, H.; Kageura, T.;
Toguchida, I.; Ueda, H.; Morikawa, T.; Yoshikawa, M. Life
Sci. 2000, 66, 2151.
Electrophoretic mobility shift assay
TGC-induced peritoneal macrophages (7.5Â106 cells/
3 mL/dish) was prepared as described above. Cells were
cultured in RPMI 1640 supplemented with 5% FCS,
penicillin (100 units/mL) and streptomycin (100 mg/mL),
20 mg/mL LPS and test compound for 4 h. Cells were
collected in ice-cold PBS and resuspended in four cell
volumes of lysis buffer (420 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 25% glycerol, 1% Nonidet P40, 20 mM
HEPES, pH 7.9). The cell lysate was incubated on ice
for 1 h, then centrifuged at 13,000 rpm at 4 ꢀC for 5 min.
The protein content of each supernatant was deter-
mined, and equal amounts of protein (20 mg) were added
to reaction mixtures containing 20 mg BSA and 32P-
labeled NF-kB consensus oligonucleotide. The oligonu-
cleotide–protein complex was separated by non-dena-
turing polyacrylamide gel electrophoresis (Gel Shift
Assay Kit, Promega), and autoradiography was per-
formed using an imaging analyzer (BAS 5000, Fuji
Film). 32P-Labeled NF-kB consensus oligonucleotide
was labeled using g-[32P]-ATP (3000 Ci/mmol) and T4
polynucleotide kinase.
7. This study was partly reported in our preliminary commu-
nication: Matsuda, H.; Kageura, T.; Morikawa, T.; Togu-
chida, I.; Harima, S.; Yoshikawa, M. Bioorg. Med. Chem.
Lett. 2000, 10, 323.
8. Rees, D. D.; Palmer, R. M.; Schulz, R.; Hodson, H. F.;
Moncada, S. Br. J. Pharmacol. 1990, 101, 746.
9. Szabo, C.; Bryk, R.; Zingarelli, B.; Southern, G. J.; Gah-
man, T. C.; Bhat, V.; Salzman, A. L.; Wolff, D. J. Br. J.
Pharmacol. 1996, 118, 1659.
iNOS Enzyme activity
10. Kashiwada, Y.; Nonaka, G.; Nishioka, I. Chem. Pharm.
Bull. 1984, 32, 3501.
11. Pan, H.; Lundgren, L. N. Phytochemistry 1995, 39, 1423.
12. Banks, H. J.; Cameron, D. W. Aust. J. Chem. 1971, 24,
2427.
13. Nakajima, K.; Taguchi, H.; Endo, T.; Yoshioka, I. Chem.
Pharm. Bull. 1978, 26, 3050.
14. Okabe, H.; Matsuo, K.; Nishioka, I. Chem. Pharm. Bull.
1973, 21, 1254.
NOS activity was measured by monitoring the conversion
of l-[U-14C]-arginine to l-[U-14C]-citrulline. Briefly, test
sample solution (5 mL) and 40 mL of substrate and
coenzyme solution [100 mM arginine (containing 50 nCi
l-[U-14C]-arginine), 1 mM NADPH, 3 mM tetra-
hydrobiopterin (BH4), 1 mM flavin adenine dinucleotide
(FAD), 1 mM flavin mononucleotide (FMN) in 25 mM
Tris–HCl buffer (pH 7.4)] were pre-incubated at 37 ꢀC
for 10 min. iNOS (20 mU/5 mL) was then added to the
reaction mixture. After incubation at 37 ꢀC for 30 min,
the reaction was terminated by addition of 400 mL of
cold buffer containing 5 mM EDTA and 50 mM HEPES
(pH 5.5). The substrate was adsorbed on AG 50W X-8
ion-exchange resin (Na+ form, 60–70 mg) packed in
spin columns. The l-citrulline, which is ionically neutral
at pH 5.5, flowed through the column completely,19 and
was mixed with a scintillation cocktail (Aquasol-2) and
radioactivity was determined using a liquid scintillation
15. Tuboi, M.; Minami, M.; Nonaka, G.; Nishioka, I. Chem.
Pharm. Bull. 1977, 25, 2708.
16. (a) Tsai, S-H.; Lin-Shiau, S-Y.; Lin, J-K. Br. J. Pharma-
col. 1999, 126, 673. (b) Manna, S. K.; Mukhopadhyay, A.;
Aggarwal, B. B. J. Immunol. 2000, 164, 6509. (c) Holmes-
McNary, M.; Baldwin, A. S., Jr. Cancer Res. 2000, 60, 3477.
17. Ding, A. H.; Nathan, D. F.; Stuehr, D. J. J. Immuol. 1988,
141, 2407.
18. Khalkhai-Ellis, Z. Prep. Biochem. 1995, 25, 1.
19. Xu, K. Y.; Huso, D. L.; Dawson, T. M.; Bredt, D. S.;
Becker, L. C. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 657.